Alveo Technologies
PrivateLast Round
Grant
May 26, 2026
Total Funding Raised
$60.85M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Alveo Technologies operates in Healthcare & Life Sciences and is based in Alameda, California. Its latest recorded funding round was a Grant round in May 2026.
Alveo Technologies is a biotechnology company that develops a portable, point-of-need molecular diagnostic platform for the rapid detection of infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Biotech Equipment, Environmental Monitoring, Sensors
Business Model
B2B
Customer Profile
Hardware + Subscription, Usage-Based SaaS, Government Contracts, Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alveo Technologies Comparables
Compare Alveo Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biomeme | 85% | |
| ProtonDx | 84% | |
| MatMaCorp | 84% |
For institutional investors. Book with your work email.
Alveo Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 26, 2026 | ||||
| Series A Extension | Apr 29, 2025 | ||||
| Grant | Nov 14, 2024 | ||||
| Series B | Aug 1, 2023 | ||||
| VC Round | Mar 29, 2021 | ||||
Grant | Mar 17, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Alveo Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Centers for Disease Control and Prevention | Grant |
| CEPI | Grant |
| H. Barton Asset Management | Series A Extension |
| Khosla Ventures | Grant |
| WRVI Capital | Series A, Series A Extension |
| Supply Change Capital | Series A Extension |
| Bill & Melinda Gates Foundation | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 122, 21.8x the trailing average.
- Apr 29, 2025
Raised Series A Extension with Black Diamond Ventures, H. Barton Asset Management, WRVI Capital, and Supply Change Capital.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withOct 1, 2026
Alveo Technologies, Inc. and Alliance announced a distribution agreement to bring the Alveo Sense Poultry avian influenza test to farmers, integrators and public health officials across Africa, Central Asia and select countries in the Eastern Mediterranean.
- partners_withSep 22, 2026
On Sep 22nd '26 in California, Alveo Technologies, Inc. and Gdanimalhealth announced an expanded partnership under which Gdanimalhealth will commit new R&D resources to develop additional molecular tests on the Alveo platform for swine, cattle, and poultry.
- partners_withSep 14, 2026
On Sep 14th '26 in California, Alveo Technologies, Inc. and AGBL Group announced a distribution agreement to bring rapid Alveo Sense Poultry avian influenza testing to farmers, integrators and public health officials across Africa, Central Asia and select Eastern Mediterranean countries.
- is_developingAug 26, 2026
On Aug 26th '26, Alveo Technologies, Inc. and AgriNerds are developing the H5N1 Surveillance System for poultry farms in the United States.
- partners_withAug 25, 2026
On Aug 25th '26 in California, Alveo Technologies, Inc. partners with AgriNerds Inc. to combine rapid on-farm molecular testing with real-time migratory bird monitoring and daily farm-level HPAI risk scores for targeted surveillance.
For institutional investors. Book with your work email.
Alveo Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Alveo Technologies's valuation, stock price, and market status.
Is Alveo Technologies a public or private company?
Alveo Technologies is a private company.
What is the current stock price of Alveo Technologies?
Alveo Technologies is a private company, so its shares have no public market price. Caplight tracks Alveo Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Alveo Technologies worth (valuation)?
Valuation information for Alveo Technologies is not publicly available.
Can I buy Alveo Technologies stock?
Alveo Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Alveo Technologies's last funding round?
Alveo Technologies's most recent funding round was Grant on May 26, 2026.
Who are the main investors in Alveo Technologies?
Key investors in Alveo Technologies include Centers for Disease Control and Prevention, CEPI, Maxim Group.
Will Alveo Technologies IPO soon?
No public IPO plans have been announced for Alveo Technologies.
How can I track Alveo Technologies secondary market activity?
Caplight tracks bids, offers, and trades in Alveo Technologies's shares on secondary markets.